MedTrace Logo

Nurse-Led Culturally Adapted Palliative and End-of-Life Training for Oncology Nurses in Oman

NCT07460570 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2026-03-10

No results posted yet for this study

Summary

This study evaluated a nurse-led, culturally adapted training program in palliative and end-of-life care (N-PELTP) for oncology nurses in Oman. Nurses in the intervention group received the structured training program, while a comparison group continued usual practice during the same period. Outcomes were assessed using questionnaires completed before and after the intervention to measure palliative care knowledge, attitudes toward caring for dying patients, self-reported palliative care practices, and communication-related outcomes. The goal of the study was to determine whether a culturally adapted educational program can improve oncology nurses' readiness to deliver palliative and end-of-life care.

Conditions

  • Neoplasms (Cancer / Tumors)
  • Palliative Care
  • Terminal Care

Interventions

BEHAVIORAL

N-PELTP Palliative and End-of-Life Training Program

A nurse-led, culturally adapted palliative and end-of-life care education and training program for oncology nurses (N-PELTP). The program was delivered in a structured format over a defined training period and covered core palliative and end-of-life care competencies, including communication and care planning. Outcomes were assessed using standardized questionnaires at baseline (pre-intervention) and after completion of the training (post-intervention

Sponsors & Collaborators

  • Sultan Qaboos University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2025-07-05
Completion
2025-07-05

Countries

  • Oman

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07460570 on ClinicalTrials.gov